DrugPatentWatch Database Preview
Ge Healthcare Company Profile
» See Plans and Pricing
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has forty-nine approved drugs.
There are seven US patents protecting GE HEALTHCARE drugs.
There are one hundred and sixteen patent family members on GE HEALTHCARE drugs in thirty-two countries and one hundred and twelve supplementary protection certificates in eighteen countries.
Summary for Ge Healthcare
| International Patents: | 116 |
| US Patents: | 7 |
| Tradenames: | 57 |
| Ingredients: | 38 |
| NDAs: | 49 |
| Drug Master File Entries: | 5 |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-002 | Oct 25, 2013 | RX | Yes | Yes | 8,236,282 | Start Trial | Y | Y | Start Trial | ||
| Ge Healthcare | CINTICHEM TECHNETIUM 99M HEDSPA | technetium tc-99m etidronate kit | INJECTABLE;INJECTION | 017653-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ge Healthcare | TECHNETIUM TC 99M GENERATOR | technetium tc-99m sodium pertechnetate generator | SOLUTION;INTRAVENOUS, ORAL | 017693-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ge Healthcare | TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT | technetium tc-99m etidronate kit | INJECTABLE;INJECTION | 017562-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ge Healthcare | TELEPAQUE | iopanoic acid | TABLET;ORAL | 008032-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ge Healthcare | OMNIPAQUE 210 | iohexol | INJECTABLE;INJECTION | 018956-006 | Jun 30, 1989 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 300 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-003 | Dec 26, 1985 | 4,396,597 | Start Trial |
| Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-001 | Sep 5, 2007 | 5,560,903 | Start Trial |
| Ge Healthcare | OMNIPAQUE 140 | iohexol | INJECTABLE;INJECTION | 018956-005 | Nov 30, 1988 | 4,250,113 | Start Trial |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | 4,396,597 | Start Trial |
| Ge Healthcare | ISOPAQUE 280 | calcium; meglumine; metrizoic acid | INJECTABLE;INJECTION | 017506-001 | Approved Prior to Jan 1, 1982 | 3,476,802 | Start Trial |
| Ge Healthcare | OMNIPAQUE 240 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-002 | Dec 26, 1985 | 4,396,597 | Start Trial |
| Ge Healthcare | OMNIPAQUE 240 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-002 | Dec 26, 1985 | 4,021,481 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 1073104 | Start Trial |
| Australia | 8670201 | Start Trial |
| Czech Republic | 9400612 | Start Trial |
| Lithuania | PA2015001 | Start Trial |
| Poland | 2182988 | Start Trial |
| Denmark | 2264018 | Start Trial |
| Slovenia | 1334091 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0290047 | SPC/GB97/078 | United Kingdom | Start Trial | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
| 2182988 | 6/2015 | Austria | Start Trial | PRODUCT NAME: (18F) - FLUTEMETAMOL; REGISTRATION NO/DATE: EU/1/14/941 (MITTEILUNG) 20140826 |
| 0268956 | 1999C0030 | Belgium | Start Trial | PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508 |
| 2673237 | 1990016-6 | Sweden | Start Trial | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326 |
| 1758590 | LUC00029 | Luxembourg | Start Trial | PRODUCT NAME: SEL DE SODIUM D'ACIDE DEOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: IS/1/16/071/01 20170401 |
| 2957286 | 132019000000021 | Italy | Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721 |
| 1611115 | 92634 | Luxembourg | Start Trial | PRODUCT NAME: FLUTEMETAMOL (18F) ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (VIZAMYL). FIRST REGISTRATION: 20140826 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
